Douglas Lane & Associates’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-17,182
Closed -$413K 247
2023
Q3
$413K Sell
17,182
-41,497
-71% -$1.02M 0.01% 184
2023
Q2
$1.36M Sell
58,679
-25,453
-30% -$576K 0.02% 142
2023
Q1
$1.86M Sell
84,132
-113,010
-57% -$2.64M 0.03% 137
2022
Q4
$4M Sell
197,142
-360,204
-65% -$6.98M 0.07% 123
2022
Q3
$7.51M Buy
557,346
+6,683
+1% +$113K 0.14% 110
2022
Q2
$10.9M Sell
550,663
-37,311
-6% -$991K 0.19% 108
2022
Q1
$18.6M Buy
587,974
+13,830
+2% +$388K 0.26% 98
2021
Q4
$12.8M Sell
574,144
-8,078
-1% -$211K 0.17% 107
2021
Q3
$16.2M Sell
582,222
-10,733
-2% -$327K 0.23% 104
2021
Q2
$23.1M Sell
592,955
-23,315
-4% -$836K 0.32% 91
2021
Q1
$17.7M Sell
616,270
-51,052
-8% -$1.74M 0.28% 94
2020
Q4
$17.7M Buy
667,322
+139,732
+26% +$2.85M 0.3% 92
2020
Q3
$8.05M Buy
527,590
+103,915
+25% +$2.18M 0.16% 105
2020
Q2
$8.61M Buy
423,675
+46,110
+12% +$827K 0.18% 101
2020
Q1
$3.9M Buy
377,565
+107,012
+40% +$2.99M 0.1% 103
2019
Q4
$10.2M Buy
270,553
+100,081
+59% +$4.5M 0.19% 98
2019
Q3
$7.95M Buy
170,472
+76,208
+81% +$3.54M 0.16% 106
2019
Q2
$4.93M Buy
94,264
+26,123
+38% +$1.53M 0.1% 110
2019
Q1
$4.7M Buy
68,141
+10,139
+17% +$680K 0.1% 111
2018
Q4
$3.46M Buy
58,002
+29,440
+103% +$2.54M 0.08% 110
2018
Q3
$3.31M Buy
28,562
+7,197
+34% +$812K 0.07% 118
2018
Q2
$2.7M Buy
21,365
+14,655
+218% +$1.78M 0.06% 122
2018
Q1
$726K Buy
6,710
+4,425
+194% +$490K 0.02% 152
2017
Q4
$250K Sell
2,285
-4,610
-67% -$460K 0.01% 188
2017
Q3
$681K Sell
6,895
-23,339
-77% -$2.26M 0.02% 159
2017
Q2
$3.06M Sell
30,234
-16,358
-35% -$1.76M 0.07% 124
2017
Q1
$5.38M Sell
46,592
-727
-2% -$84.5K 0.13% 114
2016
Q4
$5.68M Sell
47,319
-4,467
-9% -$495K 0.14% 112
2016
Q3
$5.82M Sell
51,786
-2,459
-5% -$283K 0.16% 110
2016
Q2
$6.72M Sell
54,245
-1,570
-3% -$190K 0.19% 112
2016
Q1
$6.27M Buy
+55,815
New +$5.8M 0.17% 117

Other funds holding CLB